NASDAQ:PI - Impinj Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $71.13
  • Forecasted Upside: -13.18 %
  • Number of Analysts: 8
  • Breakdown:
  • 0 Sell Ratings
  • 1 Hold Ratings
  • 7 Buy Ratings
  • 0 Strong Buy Ratings
$81.92
▼ -0.42 (-0.51%)

This chart shows the closing price for PI by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Impinj Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for PI and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for PI

Analyst Price Target is $71.13
▼ -13.18% Downside Potential
This price target is based on 8 analysts offering 12 month price targets for Impinj in the last 3 months. The average price target is $71.13, with a high forecast of $95.00 and a low forecast of $53.00. The average price target represents a -13.18% upside from the last price of $81.92.

This chart shows the closing price for PI for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 8 investment analysts is to buy stock in Impinj. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 5 buy ratings
  • 2 hold ratings
  • 0 sell ratings
6/16/2020
  • 0 strong buy ratings
  • 3 buy ratings
  • 2 hold ratings
  • 0 sell ratings
9/14/2020
  • 0 strong buy ratings
  • 4 buy ratings
  • 2 hold ratings
  • 0 sell ratings
12/13/2020
  • 0 strong buy ratings
  • 6 buy ratings
  • 1 hold ratings
  • 0 sell ratings
3/13/2021
  • 0 strong buy ratings
  • 6 buy ratings
  • 1 hold ratings
  • 0 sell ratings
6/11/2021
  • 0 strong buy ratings
  • 6 buy ratings
  • 1 hold ratings
  • 0 sell ratings
9/9/2021
  • 0 strong buy ratings
  • 7 buy ratings
  • 1 hold ratings
  • 0 sell ratings
11/8/2021
  • 0 strong buy ratings
  • 7 buy ratings
  • 1 hold ratings
  • 0 sell ratings
12/8/2021

Latest Recommendations

  • 0 strong buy ratings
  • 7 buy ratings
  • 1 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
11/17/2021Canaccord GenuityBoost Price TargetBuy$75.00 ➝ $95.00High
10/28/2021Roth CapitalBoost Price TargetBuy$68.00 ➝ $74.00High
10/28/2021Needham & Company LLCBoost Price TargetBuy$55.00 ➝ $63.00High
10/26/2021Lake Street CapitalInitiated CoverageBuy$69.00High
10/22/2021Colliers SecuritiesReiterated RatingBuy$82.00Medium
9/29/2021Piper SandlerReiterated RatingBuy$75.00High
7/29/2021Needham & Company LLCLower Price TargetIn-Line ➝ Buy$66.00 ➝ $55.00High
7/29/2021Piper SandlerLower Price TargetOverweight$74.00 ➝ $60.00High
4/29/2021Needham & Company LLCLower Price TargetBuy$77.00 ➝ $66.00High
2/11/2021Colliers SecuritiesBoost Price Target$61.00 ➝ $82.00Low
2/11/2021Roth CapitalBoost Price TargetIn-Line ➝ Buy$31.00 ➝ $74.00Low
2/11/2021Morgan StanleyBoost Price TargetEqual Weight$53.00 ➝ $58.00Low
2/11/2021Needham & Company LLCBoost Price TargetBuy$61.00 ➝ $77.00Low
2/11/2021Piper SandlerBoost Price TargetOverweight$60.00 ➝ $80.00Low
2/10/2021Canaccord GenuityBoost Price TargetBuy$55.00 ➝ $75.00Low
1/28/2021Colliers SecuritiesReiterated RatingBuyLow
1/19/2021Morgan StanleyBoost Price TargetEqual Weight$38.00 ➝ $53.00Low
1/19/2021Needham & Company LLCBoost Price TargetBuy$30.00 ➝ $61.00Low
12/14/2020The Goldman Sachs GroupBoost Price TargetBuy$46.00 ➝ $53.00Medium
12/14/2020Morgan StanleyBoost Price TargetEqual Weight$26.00 ➝ $38.00Low
12/2/2020Piper SandlerBoost Price TargetOverweight$29.00 ➝ $48.00High
11/30/2020The Goldman Sachs GroupInitiated CoverageBuy$46.00 ➝ $46.00High
10/29/2020Piper SandlerBoost Price TargetOverweight$28.00 ➝ $29.00High
10/29/2020Canaccord GenuityReiterated RatingBuy$32.00 ➝ $35.00High
7/30/2020Piper SandlerLower Price TargetOverweight$35.00 ➝ $28.00High
7/30/2020Morgan StanleyLower Price TargetEqual Weight$28.00 ➝ $26.00High
7/30/2020Needham & Company LLCReiterated RatingBuy$34.00 ➝ $30.00High
7/10/2020Piper SandlerBoost Price TargetOverweight$29.00 ➝ $35.00High
7/10/2020Needham & Company LLCBoost Price TargetBuy$25.00 ➝ $34.00High
6/16/2020Morgan StanleyBoost Price TargetEqual Weight$21.00 ➝ $28.00High
6/10/2020Canaccord GenuityReiterated RatingBuy$35.00Low
4/28/2020Canaccord GenuityLower Price TargetBuy$40.00 ➝ $35.00High
4/28/2020Needham & Company LLCBoost Price TargetBuy$19.00 ➝ $25.00High
4/27/2020Morgan StanleyLower Price TargetEqual Weight$22.00 ➝ $21.00High
3/19/2020Needham & Company LLCLower Price TargetBuy$33.00 ➝ $19.00High
3/18/2020Morgan StanleyLower Price TargetEqual Weight$31.00 ➝ $22.00Low
3/4/2020Royal Bank of CanadaLower Price TargetSector Perform$36.00 ➝ $30.00Low
3/3/2020Canaccord GenuityReiterated RatingBuy$40.00High
1/21/2020Needham & Company LLCBoost Price TargetBuy$32.00 ➝ $34.00Low
12/17/2019Needham & Company LLCUpgradeHold ➝ Buy$32.00Medium
8/16/2019Canaccord GenuityReiterated RatingBuy$39.00 ➝ $42.00High
7/30/2019Roth CapitalBoost Price TargetBuy$31.00 ➝ $38.00High
7/30/2019Canaccord GenuityBoost Price TargetBuy$35.00 ➝ $39.00High
7/30/2019Piper Jaffray CompaniesBoost Price TargetOverweight$32.00 ➝ $40.00High
7/1/2019Dougherty & CoUpgradeNeutral ➝ BuyHigh
4/30/2019Canaccord GenuityBoost Price TargetBuy$31.00 ➝ $35.00High
4/30/2019Piper Jaffray CompaniesBoost Price TargetOverweight$28.00 ➝ $32.00High
4/23/2019Roth CapitalInitiated CoverageBuy$27.00Low
2/21/2019Dougherty & CoReiterated RatingNeutralMedium
9/13/2018Piper Jaffray CompaniesBoost Price TargetOverweight$26.00 ➝ $31.00High
6/27/2018Piper Jaffray CompaniesBoost Price TargetOverweight$19.00 ➝ $26.00Medium
6/19/2018Piper Jaffray CompaniesReiterated RatingOverweight$19.00High
6/18/2018Piper Jaffray CompaniesBoost Price TargetOverweight ➝ Positive$19.00 ➝ $26.00High
5/8/2018Canaccord GenuityUpgradeHold ➝ Buy$17.00High
2/16/2018Canaccord GenuityReiterated RatingHoldHigh
2/6/2018Piper Jaffray CompaniesUpgradeNeutral ➝ OverweightMedium
2/5/2018Morgan StanleyLower Price TargetEqual Weight ➝ Equal Weight$27.00 ➝ $14.00Low
2/2/2018Piper Jaffray CompaniesLower Price TargetNeutral ➝ Neutral$27.50 ➝ $18.00High
2/2/2018Dougherty & CoDowngradeBuy ➝ NeutralHigh
2/2/2018Needham & Company LLCDowngradeBuy ➝ HoldHigh
2/2/2018Canaccord GenuityDowngradeBuy ➝ Hold$35.00 ➝ $20.00High
2/2/2018Royal Bank of CanadaDowngradeOutperform ➝ Sector Perform$17.00High
12/13/2017Morgan StanleyLower Price TargetEqual Weight$29.00 ➝ $27.00Medium
11/3/2017KeyCorpReiterated RatingHoldN/A
11/2/2017Dougherty & CoLower Price TargetBuy$62.00 ➝ $42.00N/A
11/2/2017Morgan StanleyLower Price TargetEqual Weight$37.00 ➝ $29.00N/A
11/2/2017Needham & Company LLCReiterated RatingBuy ➝ Buy$45.00 ➝ $34.00N/A
11/2/2017Canaccord GenuityReiterated RatingBuy$50.00 ➝ $35.00N/A
11/2/2017Piper Jaffray CompaniesDowngradeOverweight ➝ NeutralN/A
11/2/2017Royal Bank of CanadaLower Price TargetOutperform ➝ Outperform$50.00 ➝ $41.00N/A
10/26/2017Needham & Company LLCLower Price TargetBuy$48.00 ➝ $45.00N/A
9/29/2017Royal Bank of CanadaReiterated RatingBuyLow
9/14/2017Dougherty & CoReiterated RatingBuy$62.00Low
8/23/2017KeyCorpReiterated RatingHoldHigh
8/23/2017Dougherty & CoInitiated CoverageBuy ➝ Buy$62.00Low
8/4/2017Royal Bank of CanadaLower Price TargetOutperform ➝ Outperform$59.00 ➝ $50.00Low
8/4/2017Canaccord GenuityReiterated RatingBuy$57.00 ➝ $50.00High
7/26/2017Needham & Company LLCBoost Price TargetBuy ➝ Buy$40.00 ➝ $55.00Low
7/22/2017Royal Bank of CanadaReiterated RatingOutperformLow
6/27/2017KeyCorpDowngradeHoldN/A
6/19/2017Royal Bank of CanadaBoost Price TargetOutperform$50.00 ➝ $59.00Low
6/19/2017Morgan StanleyDowngradeOverweight ➝ Equal Weight$40.00 ➝ $51.00Medium
5/28/2017Royal Bank of CanadaReiterated RatingOutperform$42.00 ➝ $50.00Low
5/15/2017Royal Bank of CanadaLower Price TargetOutperform$44.00 ➝ $42.00N/A
5/12/2017Canaccord GenuityReiterated RatingBuy$38.00Low
5/5/2017Royal Bank of CanadaLower Price TargetOutperform ➝ Outperform$44.00 ➝ $42.00High
3/31/2017Royal Bank of CanadaReiterated RatingBuy$40.00High
3/21/2017Morgan StanleyReiterated RatingBuy$40.00Medium
3/2/2017Needham & Company LLCReiterated RatingBuy$40.00N/A
2/23/2017Morgan StanleyInitiated CoverageOverweight ➝ Overweight$40.00N/A
2/17/2017Needham & Company LLCReiterated RatingBuy$32.00 ➝ $40.00N/A
2/17/2017Royal Bank of CanadaBoost Price TargetBuy$37.00 ➝ $40.00N/A
1/23/2017Royal Bank of CanadaReiterated RatingOutperform$37.00N/A
1/11/2017Needham & Company LLCReiterated RatingBuy$32.00N/A
(Data available from 12/9/2016 forward)

News Sentiment Rating

0.37 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 9 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
5/13/2021
  • 0 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
6/12/2021
  • 0 very positive mentions
  • 8 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
7/12/2021
  • 1 very positive mentions
  • 11 positive mentions
  • 1 negative mentions
  • 1 very negative mentions
8/11/2021
  • 1 very positive mentions
  • 5 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
9/10/2021
  • 3 very positive mentions
  • 6 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
10/10/2021
  • 4 very positive mentions
  • 25 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
11/9/2021
  • 5 very positive mentions
  • 14 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
12/9/2021

Current Sentiment

  • 5 very positive mentions
  • 14 positive mentions
  • 2 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.
Impinj logo
IImpinj, Inc. engages in the development and sale of RAIN, a radio frequency identification solution. Its platform allows inventory management, patient safety, asset tracking and item authentication for the retail, healthcare, supply chain and logistics, hospitality, food and beverage, and industrial manufacturing industries. The company was founded by Carver A. Mead and Christopher Diorio in April 2000 and is headquartered in Seattle, WA.
Read More

Today's Range

Now: $81.92
Low: $80.38
High: $84.50

50 Day Range

MA: $67.85
Low: $51.22
High: $85.09

52 Week Range

Now: $81.92
Low: $38.52
High: $85.13

Volume

444,856 shs

Average Volume

272,327 shs

Market Capitalization

$2.00 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.32

Frequently Asked Questions

What sell-side analysts currently cover shares of Impinj?

The following sell-side analysts have issued research reports on Impinj in the last year: Canaccord Genuity, Colliers Securities, Lake Street Capital, Morgan Stanley, Needham & Company LLC, Piper Sandler, Roth Capital, The Goldman Sachs Group, Inc., and Zacks Investment Research.
View the latest analyst ratings for PI.

What is the current price target for Impinj?

8 Wall Street analysts have set twelve-month price targets for Impinj in the last year. Their average twelve-month price target is $71.13, suggesting a possible downside of 13.2%. Canaccord Genuity has the highest price target set, predicting PI will reach $95.00 in the next twelve months. The Goldman Sachs Group, Inc. has the lowest price target set, forecasting a price of $53.00 for Impinj in the next year.
View the latest price targets for PI.

What is the current consensus analyst rating for Impinj?

Impinj currently has 1 hold rating and 7 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe PI will outperform the market and that investors should add to their positions of Impinj.
View the latest ratings for PI.

How do I contact Impinj's investor relations team?

Impinj's physical mailing address is 400 FAIRVIEW AVENUE NORTH SUITE 1200, SEATTLE WA, 98109. The company's listed phone number is (206) 517-5300 and its investor relations email address is [email protected] The official website for Impinj is www.impinj.com.